Catalyst Wire Dossier Catalyst Wire Dossier

B1962 Injection

B1962 · Tasly Biopharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for B1962 Injection, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer [Phase 2]

See pricing